3Diraitriou R, Mataliotakis GI, Angoules AG, et al. Complications following autologous bone graft harvesting from the iliac crest and using the RIA: a systematic review [ J]. Injury, 2011, 42:3 - 15.
4Calori G, Mazza E, Colombo M, et al. The use of bone-graft substitutes in large bone defects: any specific needs? [ J ]. Injury, 2011,42:56 -63.
5Holzwarth JM, Ma PX. Biomimetic nanofibrous scaffolds for bone tissue engineering [ J ] Biomaterials, 2011, 32 ( 36 ) : 9622 - 9629.
6Lu Q, Zhang B, Li M, et al. Degradation meehanism and control of silk fibroin [J]. Biomacromolecules, 2011, 12(4) : 1080 - 1086.
7Anderson JM, Shire MS. Biodegradation and biocompatibility ofPLA and PLGA microspheres [ J ]. Advanced drug delivery reviews, 2012, 64:72 - 82.
8Karageorgiou , Meinel L, Hofmann S, et al. Bone morphogenetic protein-2 decorated silk fibroin films induce osteogenic differentiation of human bone marrow strnmal cells [ J]. Journal of Biomedical Materials Research Part A, 2004, 71 (3) : 528 -537.
9Pritchard EM, Valentin T, Boison D, et al. Incorporation of proteinase inhibitors into silk-based delivery devices for enhanced control of degradation and drug release [ J]. Biomaterials, 2011, 32(3) : 909 -918.
10Li C, Vepari C, Jin HJ, et al. Electrospun silk-BMP -2 scaffolds for bone tissue engineering [ J]. Biomaterials, 2006, 27(16) : 3115 -3124.
